Perioperative Esketamine Safety and Efficacy in Reducing Postoperative ENDometriosis PAIN (the ENDPAIN Trial): a Randomized Controlled Trial.

Opening soon

Plain-English translation of NCT07881562 on ClinicalTrials.gov ↗ · Source last updated October 2026 · How we translate trials

Read our Endometriosis research guide →

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

Key details

Phase

Post-approval monitoring

Sponsor

Region Skane

Collaborators

Sahlgrenska University Hospital, Uppsala University Hospital

Enrollment target

~1,000 participants

Started

January 2028

Primary completion

December 2030

Age range

18 Years and older

Sex

Female only

Last updated on clinicaltrials.gov in October 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Silvia Marchesi, PhD

Region Skane

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov